2017
DOI: 10.1590/0102-6720201700040013
|View full text |Cite
|
Sign up to set email alerts
|

The Role of the Sleeve Gastrectomy and the Management of Type 2 Diabetes

Abstract: Background : Currently, bariatric surgery has promoted weight loss and improved glycemic control in obese patients through different techniques, including vertical sleeve gastrectomy. Aim : Present and update the different vertical sleeve gastrectomy ways of action, both in the treatment of obesity and diabetes, approaching its potential effect on gastrointestinal physiology, as well as the benefits achieved by this manipulation. Methods : Pubmed database search was used crossing the headings: obesity, type … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
1
3

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 34 publications
0
5
1
3
Order By: Relevance
“…Likewise, our 76.6% T2D improvement rate was comparable to the 86% reported elsewhere [30]; while our 4.5% unchanged diabetes status was higher than others who reported no patients with unchanged diabetes status, probably due to their small sample size (44 patients) [31]. T2D remission after SG could be because of the dramatic reductions in caloric intake leading to decreased insulin requirement, together with an increase in glucagon-like protein-1 hormone level critical for glucose homeostasis, as well as improvements in insulin resistance associated with weight loss [32,33].…”
Section: Discussioncontrasting
confidence: 49%
“…Likewise, our 76.6% T2D improvement rate was comparable to the 86% reported elsewhere [30]; while our 4.5% unchanged diabetes status was higher than others who reported no patients with unchanged diabetes status, probably due to their small sample size (44 patients) [31]. T2D remission after SG could be because of the dramatic reductions in caloric intake leading to decreased insulin requirement, together with an increase in glucagon-like protein-1 hormone level critical for glucose homeostasis, as well as improvements in insulin resistance associated with weight loss [32,33].…”
Section: Discussioncontrasting
confidence: 49%
“…In der Studie von Bobowicz et al [18] konnte eine Verbesserung der aHTN bei 62 % der Patienten und für den DMT2 bei 68,3 % der Operierten festgestellt werden. In der Studie von Both et al [19] wurde die Effizienz von SG und dem Roux-Y-Magenbypass verglichen. Dabei wurde für die SG eine Remissionsrate von 60 % für den DMT2 nachgewiesen.…”
Section: Komorbiditätenunclassified
“…Isso é mais pronunciado nos casos de obesidade mórbida. Sendo assim, o tratamento cirúrgico da obesidade (cirurgia bariátrica) tem sido documentado como o mais efetivo, tanto na perda do excedente de peso quanto em sua manutenção a longo prazo, acarretando melhora da qualidade de vida e remissão das comorbidades que acompanham a maioria dos casos (CAZZO et al, 2016;FUCHS et al, 2017;.…”
Section: Introductionunclassified